Confronting the avian influenza threat: vaccine development for a potential pandemic
- 1 August 2004
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 4 (8) , 499-509
- https://doi.org/10.1016/s1473-3099(04)01105-3
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccineVirus Research, 2004
- Avian Influenza A (H5N1) in 10 Patients in VietnamNew England Journal of Medicine, 2004
- Molecular Evolution of H6 Influenza Viruses from Poultry in Southeastern China: Prevalence of H6N1 Influenza Viruses Possessing Seven A/Hong Kong/156/97 (H5N1)-Like Genes in PoultryJournal of Virology, 2002
- Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenzaThe Lancet, 2001
- Antibody Response in Individuals Infected with Avian Influenza A (H5N1) Viruses and Detection of Anti‐H5 Antibody among Household and Social ContactsThe Journal of Infectious Diseases, 1999
- Recombinant Influenza A Virus Vaccines for the Pathogenic Human A/Hong Kong/97 (H5N1) VirusesThe Journal of Infectious Diseases, 1999
- Replication of avian influenza viruses in humansArchiv für die gesamte Virusforschung, 1991
- Serological evidence of human infections with avian influenza virusesArchiv für die gesamte Virusforschung, 1986
- Responses of volunteers to inactivated influenza virus vaccinesEpidemiology and Infection, 1981
- Antibody Responses and Reactogenicity of Graded Doses of Inactivated Influenza A/New Jersey/76 Whole-Virus Vaccine in HumansThe Journal of Infectious Diseases, 1977